Evolution Optiks Ltd. is pleased to announce that it had engaged Hogan Lovells as FDA counsel. In preparation for the market launch of its innovative tele-medicine devices, the company is seeking regulatory approval. With 45 years of experience in the regulatory landscape and a committed team of more than 30 medical equipment experts with scientific backgrounds, Hogan Lovells is a highly ranked and award-winning legal services provider, operating on a global scale.
“Hogan Lovells was the obvious choice for us. Their deep knowledge and understanding of the regulatory framework, coupled with extensive international experience are invaluable assets to our company. We have every confidence that they are the right partners to guide us through the process and expedite FDA approval. Our technology is a vital tool for teleconsultation in the fast-growing sector of telemedicine, the call of the hour in times of a global pandemic. We look forward to a long-term relationship with Hogan Lovells as we seek to launch several innovative products in the future”, said Raul Mihali, CEO of Evolution Optiks Ltd.
Headquartered in London and Washington D.C., Hogan Lovells was formed in 2010 by the merger of the US law firm of Hogan & Hartson and the British law firm of Lovells. They practice in the fields of corporate and finance, global regulatory, intellectual property, media and technology, litigation, arbitration and employment. In 2019, their total revenue was US$ 2.25 bn which made them the 11th largest law firm in the world by global revenue. They have 47 offices in 24 countries throughout the Americas, Asia Pacific, Europe, the Middle East, and Africa.